LH vs THC
Labcorp Holdings Inc. and Tenet Healthcare Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | LH | THC |
|---|---|---|
| Revenue | $14.0B | $21.3B |
| Net income | $876.5M | $2.4B |
| Gross margin | 28.8% | · |
| Net margin | 6.3% | 11.1% |
| Return on equity | 10.5% | · |
| Diluted EPS | $10.46 | $15.49 |
| Dividend / share | $2.88 | · |
| Payout ratio | 27.5% | · |
| Free cash flow | $1.2B | $2.5B |
| Equity | $8.6B | $4.2B |
| Net debt / equity | 0.59× | 2.42× |
| Current ratio | 1.42× | 1.76× |
| Revenue CAGR 5y | −0.0% | 3.9% |
| Profit CAGR 5y | −10.8% | 25.2% |
THC bills 1.5× the revenue of LH, and keeps more of each dollar of revenue as profit (11.1% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | LH | THC |
|---|---|---|
| FY2025 | $14.0B | $21.3B |
| FY2024 | $13.0B | $20.7B |
| FY2023 | $12.2B | $20.6B |
| FY2022 | $11.9B | $19.2B |
| FY2021 | $13.1B | $19.5B |
| FY2020 | $14.0B | $17.6B |
| FY2019 | $11.6B | $18.5B |
| FY2018 | $11.3B | $18.3B |
| FY2017 | $10.3B | $20.6B |
| FY2016 | $9.6B | $21.1B |
Bottom line
| Fiscal year | LH | THC |
|---|---|---|
| FY2025 | $876.5M | $2.4B |
| FY2024 | $746.0M | $4.1B |
| FY2023 | $418.0M | $1.3B |
| FY2022 | $1.3B | $1.0B |
| FY2021 | $2.4B | $1.5B |
| FY2020 | $1.6B | $768.0M |
| FY2019 | $823.8M | $171.0M |
| FY2018 | $883.7M | $459.0M |
| FY2017 | $1.2B | $-320.0M |
| FY2016 | $711.8M | $176.0M |
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$7,358,300,000 | THC |
| FY2024 | −$7,666,100,000 | THC |
| FY2023 | −$8,402,400,000 | THC |
| FY2022 | −$7,310,100,000 | THC |
| FY2021 | −$6,348,900,000 | THC |
| FY2020 | −$3,661,500,000 | THC |
| FY2019 | −$6,924,200,000 | THC |
| FY2018 | −$6,979,600,000 | THC |
| FY2017 | −$10,305,000,000 | THC |
| FY2016 | −$11,517,100,000 | THC |
| FY2015 | −$11,430,900,000 | THC |
| FY2014 | −$11,896,400,000 | THC |
| FY2013 | −$6,250,700,000 | THC |
| FY2012 | −$4,232,600,000 | THC |
| FY2011 | −$3,111,700,000 | THC |
| FY2010 | −$3,261,100,000 | THC |
| FY2009 | −$3,623,300,000 | THC |
| FY2008 | −$4,079,800,000 | THC |
THC has reported the higher revenue in every one of these 18 fiscal years. The gap has widened since the earliest year compared.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −4.8 pp | THC |
| FY2024 | −13.9 pp | THC |
| FY2023 | −2.9 pp | THC |
| FY2022 | +5.6 pp | LH |
| FY2021 | +10.5 pp | LH |
| FY2020 | +6.8 pp | LH |
| FY2019 | +6.2 pp | LH |
| FY2018 | +5.3 pp | LH |
| FY2017 | +13.5 pp | LH |
| FY2016 | +6.6 pp | LH |
| FY2015 | +4.7 pp | LH |
| FY2014 | +8.1 pp | LH |
| FY2013 | +10.8 pp | LH |
| FY2012 | +9.0 pp | LH |
| FY2011 | +8.5 pp | LH |
| FY2010 | −2.5 pp | THC |
| FY2009 | +9.5 pp | LH |
| FY2008 | +10.2 pp | LH |
The higher net margin has changed hands between LH and THC over this period.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's net margin has been more volatile than LH's over the 18 comparable fiscal years — 5.5 percentage points of standard deviation against 3.2.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between LH and THC over these 18 fiscal years — LH led in 14 and THC in 4.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's return on equity has been more volatile than LH's over the 3 comparable fiscal years — 31.2 percentage points of standard deviation against 1.8.
3 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between LH and THC over these 3 fiscal years — LH led in 1 and THC in 2.
3 of 19 comparable fiscal years — a year missing data on either side is not counted.